Chantal Petit
YOU?
Author Swipe
View article: Design of Resolve Lung, a Multinational Phase 2, Randomized, Placebo-Controlled Trial of the Anti-Gm-Csf Monoclonal Antibody Namilumab in Patients with Chronic Pulmonary Sarcoidosis
Design of Resolve Lung, a Multinational Phase 2, Randomized, Placebo-Controlled Trial of the Anti-Gm-Csf Monoclonal Antibody Namilumab in Patients with Chronic Pulmonary Sarcoidosis Open